HCM
GNLX icon

Heights Capital Management’s Genelux GNLX Stock Holding History

Heights Capital Management’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-238,366
Closed -$644K – 175
2025
Q1 		$644K Buy
+238,366
New +$894K 0.3% 40

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
PWM
Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Heights Capital Management's GNLX Position: Q2 2025 in Review

Heights Capital Management sold out of Genelux (GNLX) in Q2 2025, closing a stake of 238,366 shares — an estimated $644K sold.

Heights Capital Management first reported a position in GNLX in Q1 2025 and held it in 1 quarter. The position peaked at $644K in Q1 2025. 61 funds tracked by Wall St. Rank hold GNLX as of Q2 2025.

  • Heights Capital Management reported no remaining Genelux position as of Q2 2025 after selling out during the quarter.
  • Heights Capital Management sold 238,366 Genelux shares in Q2 2025, an estimated $644K.
  • Heights Capital Management first reported a position in Genelux in Q1 2025 and held it in 1 quarter.
  • Heights Capital Management's Genelux position peaked at $644K in Q1 2025.
  • 61 funds tracked by Wall St. Rank held Genelux as of Q2 2025.

Based on Heights Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.